Volume 12, Number 4—April 2006
Research
Economic Impact of Lyme Disease
Table 3
Diagnosis group‡ | Cohort | No. cases | Cost per case (US$) |
Significance§ |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Median | Mean | Minimum | Maximum | SD | 1997 | 1998 | 1999 | 2000 | |||
Early-stage LD | 1997 | 77 | 565 | 1,609 | 95 | 11,286 | 2,010 | NA | |||
1998 | 63 | 337 | 869 | 78 | 9,720 | 1,542 | S | NA | |||
1999 | 122 | 282 | 455 | 42 | 3,574 | 630 | S | NS | NA | ||
2000 | 72 | 288 | 464 | 5 | 5,338 | 738 | S | NS | NS | NA | |
Late-stage LD | 1997 | 28 | 3,673 | 4,240 | 275 | 24,985 | 5,132 | NA | |||
1998 | 24 | 654 | 1,472 | 125 | 6,417 | 1,839 | S | NA | |||
1999 | 59 | 588 | 1,286 | 74 | 5,402 | 1,334 | S | NS | NA | ||
2000 | 45 | 589 | 1,380 | 45 | 6,918 | 1,652 | S | NS | NS | NA | |
Suspected LD | 1997 | 153 | 169 | 326 | 45 | 9,564 | 948 | NA | |||
1998 | 79 | 174 | 255 | 48 | 2,285 | 281 | NS | NA | |||
1999 | 242 | 198 | 321 | 51 | 3,869 | 445 | NS | NS | NA | ||
2000 | 244 | 238 | 361 | 42 | 7,816 | 601 | NS | NS | NS | NA | |
Tick bite | 1997 | 143 | 92 | 140 | 33 | 836 | 129 | NA | |||
1998 | 55 | 93 | 227 | 34 | 3,432 | 502 | S | NA | |||
1999 | 202 | 87 | 120 | 17 | 527 | 98 | NS | S | NA | ||
2000 | 139 | 70 | 121 | 16 | 1,181 | 141 | NS | S | NS | NA | |
Other | 1997 | 490 | 196 | 319 | 8 | 6,236 | 495 | NA | |||
1998 | 154 | 273 | 479 | 34 | 3,721 | 561 | S | NA | |||
1999 | 573 | 215 | 321 | 36 | 5,091 | 435 | NS | S | NA | ||
2000 | 451 | 256 | 381 | 17 | 4,157 | 452 | NS | NS | NS | NA |
*Direct medical costs were collected from medical record abstraction (1997–2000). Direct medical costs of LD included costs of physician visits, consultation, serologic testing, procedure, therapy, hospitalization/ER, and other relevant costs.
†All costs were converted to 2000 equivalent.
‡Patients were divided into 5 diagnosis groups: clinically defined early-stage LD, clinically defined late-stage LD, suspected LD, tick bite, and other related complaints.
§Differences between annual mean direct medical costs were analyzed by using 1-way analysis of variance followed by Bonferroni test; p<0.05; SD, standard deviation; NA, not available; S, significant; NS, not significant.
1Current affiliation: Maryland Department of Health and Mental Hygiene, Baltimore, Maryland, USA